Visual Outcomes After Implantation of a New Multifocal Intraocular Lens

Sponsor
Hospital Oftalmologico de Brasilia (Other)
Overall Status
Completed
CT.gov ID
NCT01505816
Collaborator
University of Sao Paulo (Other)
40
1
1
3
13.2

Study Details

Study Description

Brief Summary

This prospective nonrandomized study comprised patients with cataract, corneal astigmatism, and motivation for spectacle independence. In all cases, a Rayner M-flex® T toric Intraocular Lens will be implanted in the capsular bag. Three months postoperatively, distance, intermediate, and near visual acuities; spherical equivalent; residual refractive astigmatism; defocus curve; and contrast sensitivity will be evaluated. A patient-satisfaction and visual phenomena questionnaire will also be administered.

Condition or Disease Intervention/Treatment Phase
  • Device: Multifocal Intraocular Lens (RAYNER M-FLEX T TORIC IOL)
Phase 4

Detailed Description

Postoperative evaluation was performed at 3 months. The uncorrected and corrected distance visual acuity were assessed using the 100% contrast Early Treatment Diabetic Retinopathy Study chart, uncorrected intermediate visual acuity at 70 cm, and uncorrected near visual acuity at 40 cm; a binocular defocus curve was constructed using the ETDRS chart at 4 m and adding to the patient's manifest refraction +2.50 to -5.00 D sphere in 0.50 increments. The cylinder axis of the Intraocular lens (IOL) was measured at the slitlamp using the beam protractor after full mydriasis. The mean of the absolute values of degrees the intraocular lens was off axis was determined.

Contrast sensitivity was measured using the CSV-1000 HGT instrument (VectorVision, Inc.), which presents a translucent chart divided into 4 cycles with spatial frequencies of 3, 6, 12 and 18 cycles per degree. The background illumination of the translucent chart does not depend on room lighting. All measurements were obtained under mesopic (5 cd/m2) and photopic (85 cd/m2) conditions. The examinations were performed unilaterally at a distance of 2.5 m with Best-corrected visual acuity (BCVA) and an undilated pupil. All measurements were performed under the same conditions.

Patient satisfaction and quality of life were assessed by a simple questionnaire. Patients were interviewed 3 months postoperative. Patients were asked about visual disturbances, visual lifestyle activities, spectacle use, and satisfaction with the procedure.

Study Design

Study Type:
Interventional
Actual Enrollment :
40 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Visual Outcomes After Implantation of a New Refractive Toric Multifocal Intraocular Lens
Study Start Date :
Oct 1, 2011
Actual Primary Completion Date :
Nov 1, 2011
Actual Study Completion Date :
Jan 1, 2012

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Toric

Multifocal Toric IOL implantation

Device: Multifocal Intraocular Lens (RAYNER M-FLEX T TORIC IOL)
Multifocal IOL implantation
Other Names:
  • RAYNER M-FLEX T TORIC IOL
  • Outcome Measures

    Primary Outcome Measures

    1. Visual Performance After Implantation of a Toric Multifocal Refractive Intraocular Lens [3 months postoperative]

      Postoperative evaluation will be performed at 3 months. The uncorrected distance visual acuity (UDVA) and corrected distance visual acuity (CDVA) will be assessed using the 100% contrast ETDRS chart; a binocular defocus curve will be constructed using the ETDRS chart at 4 m.

    Secondary Outcome Measures

    1. Contrast sensitivity [3 months]

      Contrast sensitivity will be measured using the CSV-1000 HGT instrument (VectorVision, Inc.), which presents a translucent chart divided into 4 cycles with spatial frequencies of 3, 6, 12 and 18 cycles per degree (cpd). The background illumination of the translucent chart does not depend on room lighting. All measurements will be obtained under mesopic (5 cd/m2) and photopic (85 cd/m2) conditions. The examinations will be performed unilaterally at a distance of 2.5 m with BCVA and an undilated pupil. All measurements will be performed under the same conditions.

    2. Patient satisfaction [3 months]

      Patient satisfaction and quality of life will be assessed by a simple questionnaire. Patients will be interviewed 3 months postoperative. Patients will be asked about visual disturbances, visual lifestyle activities, spectacle use, and satisfaction with the procedure.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    55 Years to 85 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Cataract

    • Any race

    • Either gender

    • Diagnosis of cataracts both eyes

    • Pre-existing physical conditions that could skew visual results, such as Diabetes, Retinal detachment, Macular degeneration, or Cancer

    • Subjects must have > 1.00 diopter of astigmatism

    Exclusion Criteria:
    • Central endothelial cell count less than 2000 cells/mm2 glaucoma or intraocular pressure greater than 21 mmHg amblyopia

    • Retinal abnormalities

    • Diabetes mellitus steroid or immunosuppressive treatment

    • Connective tissue diseases

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Hospital Oftalmologico Brasilia Brasilia DF Brazil 70200670

    Sponsors and Collaborators

    • Hospital Oftalmologico de Brasilia
    • University of Sao Paulo

    Investigators

    • Principal Investigator: PATRICK F TZELIKIS, MD, PhD, HOSPITAL OFTALMOLOGICO BRASILIA

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    Responsible Party:
    PATRICK FRENSEL DE MORAES TZELIKIS, Principal Investigator, Hospital Oftalmologico de Brasilia
    ClinicalTrials.gov Identifier:
    NCT01505816
    Other Study ID Numbers:
    • HOB05
    • HOBBrasilia05
    First Posted:
    Jan 9, 2012
    Last Update Posted:
    Jan 9, 2012
    Last Verified:
    Jan 1, 2012
    Keywords provided by PATRICK FRENSEL DE MORAES TZELIKIS, Principal Investigator, Hospital Oftalmologico de Brasilia
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jan 9, 2012